W. Nicholas Haining

Dr. W. Nicholas Haining BM BCh is a physician-scientist and Vice-President, Discovery Oncology at Merck and Co. Dr. Haining received his undergraduate and medical degree from Oxford University, UK, and completed his medical training in Pediatrics at Children's Hospital, Boston, and subsequently in Pediatric Hematology/Oncology at Dana-Farber Cancer Institute. As an Associate Professor of Pediatrics at Harvard Medical School and an Associate Member of the Broad Institute of Harvard and MIT his lab defined some of the key transcriptional and epigenetic regulators of T cell exhaustion and used in vivo genetic screens to identify immune vulnerabilities of cancer cells in mouse models. At Merck, he leads a multi-disciplinary organization focused on using innovative approaches identify new therapeutic strategies for cancer and immunological disease.